Hydrazine → HCID 58542054, 화합물

반응식

[Br:1][C:2]1[CH:28]=[CH:27][C:5]2[N:6]([C:23]([CH3:26])([CH3:25])[CH3:24])[C:7]([C:9]3[CH:22]=[CH:21][CH:20]=[CH:19][C:10]=3[C:11](/[N:13]=[C:14](/[N:16](C)C)\[CH3:15])=O)=[N:8][C:4]=2[CH:3]=1.[NH2:29]N>C(O)(=O)C.CCOC(C)=O>[Br:1][C:2]1[CH:28]=[CH:27][C:5]2[N:6]([C:23]([CH3:26])([CH3:25])[CH3:24])[C:7]([C:9]3[CH:22]=[CH:21][CH:20]=[CH:19][C:10]=3[C:11]3[N:13]=[C:14]([CH3:15])[NH:16][N:29]=3)=[N:8][C:4]=2[CH:3]=1

참가 물질

실험 절차

To a round bottom flask is added 2-(5-bromo-1-tert-butyl-1H-benzimidazol-2-yl)-N-[1-dimethylamino-eth-(E)-ylidene]-benzamide (237 mg, 0.537 mmol) in glacial acetic acid (3 mL), followed by the addition of hydrazine (35% wt solution in water) (2 mL). The reaction mixture is stirred at room temperature for 2 hours. The reaction mixture is diluted with EtOAc, is washed with sat. NaHCO3, brine, dried under anhy. Na2SO4, filtered and concentrated. The residue is loaded to a silica gel column. The column is eluted with 0-3% 2M NH3 in MeOH/CH2Cl2. The product fractions are collected and concentrated to afford 5-bromo-1-tert-butyl-2-[2-(5-methyl-1H-1,2,4-triazol-3-yl)-phenyl]-1H-benzimidazole (78 mg, 35%) as a light brown solid. LCMS (ESMS): m/z 410.68, 412.71 (M++1)